White Paper
Sponsored by Noom Health
As obesity rates rise, GLP-1 medications are gaining popularity. Yet, the multifactorial obesity epidemic presents challenges for organizations as more employees seek GLP-1’s. This white paper explores actionable strategies to help cut costs, improve employee health outcomes, and achieve a measurable ROI.